lipoxin a4 and Hypertension

lipoxin a4 has been researched along with Hypertension in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Özdemir, AT; Yücel, H	1
Das, UN	1

Reviews

1 review(s) available for lipoxin a4 and Hypertension

Article	Year
Vitamin C for Type 2 Diabetes Mellitus and Hypertension. Archives of medical research, 2019, Volume: 50, Issue:2 Topics: Alprostadil; Ascorbic Acid; Cytoprotection; Diabetes Mellitus, Type 2; Dietary Supplements; Epoprostenol; Fatty Acids, Essential; Humans; Hyperglycemia; Hypertension; Lipoxins; Nitric Oxide; Pancreas	2019

Other Studies

1 other study(ies) available for lipoxin a4 and Hypertension

Article	Year
Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension. Prostaglandins, leukotrienes, and essential fatty acids, 2021, Volume: 174 Topics: Adult; Arachidonate 15-Lipoxygenase; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Lipoxins; Male; Middle Aged; Oxidation-Reduction; Risk Factors	2021

Article

Year

Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension.

Prostaglandins, leukotrienes, and essential fatty acids, 2021, Volume: 174

Topics: Adult; Arachidonate 15-Lipoxygenase; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Lipoxins; Male; Middle Aged; Oxidation-Reduction; Risk Factors

2021